Clincosm LogoSign in Get a demo

Carcinoma of Unknown Primary

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

Active, not recruiting
  • Analgesia
  • +6 more
  • Copenhagen, Denmark
    Department of Otorhinolaryngology, Head and Neck Surgery & Audio
Oct 14, 2022

Breast Carcinoma, Carcinoma of Unknown Primary, CNS Carcinoma Trial in Scottsdale, Jacksonville (Biospecimen Collection, Genetic

Recruiting
  • Breast Carcinoma
  • +10 more
  • Biospecimen Collection
  • Genetic Testing
  • Scottsdale, Arizona
  • +1 more
Jul 15, 2022

Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

Recruiting
  • Carcinoma of Unknown Primary
  • Pembrolizumab Injection
  • Calgary, Alberta, Canada
  • +2 more
Feb 18, 2022

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting
  • Solid Tumor
  • +15 more
  • RAPA-201 Rapamycin Resistant T Cells
  • Chemotherapy Prior to RAPA-201 Therapy
  • Hackensack, New Jersey
    Hackensack University Medical Center
Dec 23, 2021

Carcinoma of Unknown Primary, Pain Trial in United States (gemcitabine HCl, quality-of-life assessment)

Completed
  • Carcinoma of Unknown Primary
  • Pain
  • gemcitabine hydrochloride
  • quality-of-life assessment
  • Chicago, Illinois
  • +36 more
Oct 29, 2020

Head-and-neck Cancer, Carcinoma of Unknown Primary Trial in Shanghai (Elective mucosal irradiaton)

Unknown status
  • Head-and-neck Cancer
  • Carcinoma of Unknown Primary
  • Elective mucosal irradiaton
  • Shanghai, Shanghai, China
  • +1 more
Apr 7, 2019

Carcinoma of Unknown Primary Trial in Worldwide (radiation therapy)

Completed
  • Carcinoma of Unknown Primary
  • radiation therapy
  • Birmingham, Alabama
  • +261 more
Jul 6, 2018

PET Scans and CT Scans in Locally Advanced Head and Neck Cancer

Completed
  • Carcinoma of Unknown Primary
  • Head and Neck Cancer
    • Winston-Salem, North Carolina
      Wake Forest University Comprehensive Cancer Center
    May 25, 2017

    Carcinoma of Unknown Primary, Colorectal Cancer, Solid Tumor Trial in Memphis (drug, procedure, radiation)

    Completed
    • Carcinoma of Unknown Primary
    • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 24, 2017

    Carcinoma of Unknown Primary Trial in United States (gemcitabine HCl, irinotecan HCl)

    Completed
    Has Results
    • Carcinoma of Unknown Primary
    • gemcitabine hydrochloride
    • irinotecan hydrochloride
    • Mason City, Iowa
    • +3 more
    Feb 17, 2017

    Bladder Cancer, Brain and CNS Tumors, Carcinoma of Unknown Primary Trial in Boston (biological, drug, procedure)

    Completed
    • Bladder Cancer
    • +10 more
    • filgrastim
    • +5 more
    • Boston, Massachusetts
    • +2 more
    Jan 19, 2017

    Carcinoma of Unknown Primary, Head Neck Cancer Trial in Miami (drug, procedure, radiation)

    Completed
    • Carcinoma of Unknown Primary
    • Head and Neck Cancer
    • amifostine trihydrate
    • +5 more
    • Miami, Florida
      Sylvester Cancer Center, University of Miami
    Dec 14, 2016

    Carcinoma of Unknown Primary Trial in Seoul (gemcitabine/docetaxel combination)

    Unknown status
    • Carcinoma of Unknown Primary
    • gemcitabine/docetaxel combination
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Oct 27, 2015

    Carcinoma of Unknown Primary Trial in Worldwide (belinostat, carboplatin, paclitaxel, carboplatin, paclitaxel)

    Completed
    Has Results
    • Carcinoma of Unknown Primary
    • belinostat, carboplatin, paclitaxel
    • carboplatin, paclitaxel
    • Fort Myers, Florida
    • +22 more
    Jul 7, 2015

    Carcinoma of Unknown Primary Trial in United States (capecitabine, docetaxel, gemcitabine HCl)

    Withdrawn
    • Carcinoma of Unknown Primary
    • Hamilton, New Jersey
    • +5 more
    May 22, 2015

    Carcinoma of Unknown Primary Trial in Manchester (cisplatin, cyclophosphamide, doxorubicin HCl)

    Unknown status
    • Carcinoma of Unknown Primary
    • Manchester, England, United Kingdom
      Christie Hospital N.H.S. Trust
    Sep 19, 2013

    Bladder Cancer, Breast Cancer, Carcinoma of Unknown Primary Trial in Lebanon (filgrastim, docetaxel, gemcitabine HCl)

    Completed
    • Bladder Cancer
    • +11 more
    • filgrastim
    • +2 more
    • Lebanon, New Hampshire
      Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Cente
    Aug 27, 2013

    Carcinoma of Unknown Primary Trial in Maastricht, Tilburg (carboplatin, etoposide, fluorouracil)

    Unknown status
    • Carcinoma of Unknown Primary
    • Maastricht, Netherlands
    • +1 more
    Aug 6, 2013

    Carcinoma of Unknown Primary, Head Neck Cancer Trial in New Haven (mitomycin C, porfiromycin, brachytherapy)

    Completed
    • Carcinoma of Unknown Primary
    • Head and Neck Cancer
    • mitomycin C
    • +3 more
    • New Haven, Connecticut
      Yale Comprehensive Cancer Center
    Jul 24, 2013

    Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma of the Skin Trial in New York (irinotecan HCl)

    Completed
    • Carcinoma of Unknown Primary
    • +2 more
    • irinotecan hydrochloride
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Jun 18, 2013

    Carcinoma of Unknown Primary, Lung Cancer Trial in Baltimore, Philadelphia (biological, drug, procedure)

    Completed
    • Carcinoma of Unknown Primary
    • Lung Cancer
    • filgrastim
    • +5 more
    • Baltimore, Maryland
    • +1 more
    Apr 16, 2013

    Brain and CNS Tumors, Carcinoma of Unknown Primary, Leukemia Trial in United States (topotecan HCl)

    Terminated
    • Brain and Central Nervous System Tumors
    • +4 more
    • topotecan hydrochloride
    • San Francisco, California
    • +10 more
    Jun 29, 2011